TEE
BIOR

Tibra Equities Europe’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Tibra Equities Europe’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-264
Closed -$236K – 239
2021
Q2 		$236K Buy
+264
New +$202K 0.07% 224

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tibra Equities Europe's BIOR Position: Q3 2021 in Review

Tibra Equities Europe sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2021, closing a stake of 264 shares — an estimated $236K sold.

Tibra Equities Europe first reported a position in BIOR in Q2 2021 and held it in 1 quarter. The position peaked at $236K in Q2 2021. 35 funds tracked by Wall St. Rank hold BIOR as of Q3 2021.

  • Tibra Equities Europe reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 264 Biora Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $236K.
  • Tibra Equities Europe first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Tibra Equities Europe's Biora Therapeutics, Inc. Common Stock position peaked at $236K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.